26
U. Aich, D. Loganathan / Carbohydrate Research 341 (2006) 19–28
20.7, 20.6 (3 · COCH3); ESI-MS: Calcd for
3), 4.34 (t, 1H, J = 6.6 Hz, H-5), 4.16–4.07 (m, 3H, H-
2, H-6a, H-6b), 2.32 (s, 3H, PhCH3-p), 2.18, 2.11, 2.08
(3s, 3H each, COCH3); 13C NMR (100 MHz, CDCl3):
d 170.8, 170.3, 170.1 (3 · COCH3), 154.1 (C-10), 133.0
(C-40), 130.1 (C-20, C-60), 116.9 (C-30, C-50), 98.0 (C-
1), 70.6, 68.1, 67.5, 67.2, 61.6 (C-6), 29.6 (PhCH3-p),
20.8, 20.6, 20.5 (COCH3); ESI-MS: Calcd for
C19H24O9Na ([M+Na]+): 419.1318, found: 419.1339.
C19H24O10Na ([M+Na]+): 435.1267, found: 435.1280.
3.6. p-Chlorophenyl 3,4,6-tri-O-acetyl-a-D-glucopyran-
oside (6d)
1
[a]D +60.2 (c 1, CH2Cl2); H NMR (400 MHz, CDCl3):
d 7.30 (d, 2H, J = 8.9 Hz, H-30, H-50), 7.09 (d, 2H,
J = 8.9 Hz, H-20, H-60), 5.57 (d, 1H, J = 3.7 Hz, H-1),
5.45 (t, 1H, J = 9.8 Hz, H-3), 5.13 (t, 1H, J = 9.8 Hz,
H-4), 4.27 (dd, 1H, J = 4.6, 12.1 Hz, H-6a), 4.10 - 4.02
(m, 2H, H-5, H-6b), 3.89 (dd, 1H, J = 3.7, 9.9 Hz, H-
2), 2.14, 2.07, 2.06 (3s, 3H each, COCH3); 13C NMR
(100 MHz, CDCl3): d 171.3, 170.5, 169.5 (3 · COCH3),
154.6 (C-10), 129.7 (C-40), 128.4 (C-20, C-60), 118.0 (C-
30, C-50), 97.2 (C-1), 73.2, 70.8, 68.5, 67.6, 61.6 (C-6),
20.8, 20.6, 20.5 (COCH3); ESI-MS: Calcd for
C18H21O9NaCl ([M+Na]+): 439.0772, found: 439.0772.
3.10. p-Methoxyphenyl 3,4,6-tri-O-acetyl-a-D-galacto-
pyranoside (7c)
[a]D +117.1 (c 1, CH2Cl2); 1H NMR (400 MHz, CDCl3):
d 7.05 (d, 2H, J = 9.1 Hz, H-20, H-60), 6.86 (d, 2H,
J = 9.1 Hz, H-30, H-50), 5.54 (d, 1H, J = 3.6 Hz, H-1),
5.50 (d, 1H, H-4), 5.36 (dd, 1H, J = 3.2, 10.4 Hz, H-
3), 4.40 (t, 1H, J = 6.6 Hz, H-5), 4.14–4.10 (m, 3H, H-
2, H-6a, H-6b), 3.80 (s, 3H, PhOCH3-p), 2.18, 2.11,
2.20 (3s, 3H each, COCH3); 13C NMR (100 MHz,
CDCl3): d 170.9, 170.4, 170.2 (3 · COCH3), 155.6 (C-
10), 150.2 (C-40), 118.4 (C-20, C-60), 114.7 (C-30, C-50),
98.6 (C-1), 70.6, 68.2, 67.5, 67.2, 61.8 (C-6), 55.6
(PhOCH3-p), 20.8, 20.7, 20.6 (COCH3); ESI-MS: Calcd
for C19H24O10Na ([M+Na]+): 435.1267, found:
435.1262.
3.7. p-Fluorophenyl 3,4,6-tri-O-acetyl-a-D-glucopyran-
oside (6e)
Mp 136 ꢁC; [a]D +30.2 (c 1, CH2Cl2); 1H NMR
(400 MHz, CDCl3): d 7.14–6.99 (m, 4H, C6H4F-p),
5.52 (d, 1H, J = 3.7 Hz, H-1), 5.44 (t, 1H, J = 9.8 Hz,
H-3), 5.12 (t, 1H, J = 9.8 Hz, H-4), 4.25 (dd, 1H,
J = 4.0, 12.1 Hz, H-6a), 4.13–4.06 (m, 2H, H-5, H-6b),
3.87 (dd, 1H, J = 3.8, 9.9 Hz, H-2), 2.13, 2.07, 2.06
(3s, 3H each, COCH3); 13C NMR (100 MHz, CDCl3):
0
3.11. p-Chlorophenyl 3,4,6-tri-O-acetyl-a-D-galacto-
pyranoside (7d)
d 171.3, 170.5, 169.6 (3 · COCH3), 158.7 (JC4 ,F
=
[a]D +147.3 (c 1, CH2Cl2); 1H NMR (400 MHz, CDCl3):
d 7.30 (d, 2H, J = 8.8 Hz, H-30, H-50), 7.07 (d, 2H,
J = 8.8 Hz, H-20, H-60), 5.62 (d, 1H, J = 3.7 Hz, H-1),
5.49 (d, 1H, H-4), 5.36 (dd, 1H, J = 3.2, 10.4 Hz, H-
3), 4.30 (t, 1H, J = 6.4 Hz, H-5), 4.19–4.05 (m, 3H, H-
2, H-6a, H-6b), 2.18, 2.11, 1.98 ppm (3s, 3H each,
COCH3); 13C NMR (100 MHz, CDCl3): d 170.8,
170.3, 170.1 (3 · COCH3), 154.7 (C-10), 129.6 (C-40),
128.3, 118.2, 97.9 (C-1), 70.4, 68.0, 67.8, 67.1, 61.6 (C-
6), 20.8–20.6, (3 · COCH3); ESI-MS: Calcd for
C18H21O9NaCl ([M+Na]+): 439.0772, found: 439.0781.
240.1 Hz, C-40), 152.2 (C-10), 118.1 (JC ,F = 8.2 Hz,
0
C-20, C-60), 116.2 (JC ,F = 23.1 Hz, C-30, C-50), 97.2
0
(C-1), 73.2, 70.8, 68.4, 67.7, 61.8 (C-6), 20.8, 20.6, 20.5
(COCH3); ESI-MS: Calcd for C18H21O9FNa
([M+Na]+): 423.1067, found: 423.1058.
3.8. Phenyl 3,4,6-tri-O-acetyl-a-D-galactopyranoside (7a)
Mp 168 ꢁC; [a]D +117.1 (c 1, CH2Cl2); 1H NMR
(400 MHz, CDCl3): d 7.38–7.08 (m, 5H, Ph), 5.68 (d,
1H, J = 3.8 Hz, H-1), 5.50 (d, 1H, H-4), 5.39 (dd, 1H,
J = 3.5, 10.8 Hz, H-3), 4.35 (t, 1H, J = 6.9 Hz, H-5),
4.20–4.06 (m, 3H, H-2, H-6a, H-6b), 2.19, 2.07, 1.98
(3s, 3H each, COCH3); 13C NMR (100 MHz, CDCl3):
d 170.8, 170.4, 170.1 (3 · COCH3), 156.1 (C-10), 129.7,
128.1, 116.8, 97.6 (C-1), 70.6, 68.2, 67.6, 67.1, 61.6 (C-
6), 20.8, 20.6, 20.5 (COCH3); ESI-MS: Calcd for
C18H22O9Na ([M+Na]+): 405.1162, found: 405.1161.
3.12. p-Fluorophenyl 3,4,6-tri-O-acetyl-a-D-galacto-
pyranoside (7e)
Mp 127 ꢁC; [a]D +177.9 (c 1, CH2Cl2); 1H NMR
(400 MHz, CDCl3): d 7.09–6.99 (m, 4H, C6H4F-p),
5.56 (d, 1H, J = 3.9 Hz, H-1), 5.47 (d, 1H, H-4), 5.35
(dd, 1H, J = 3.4, 10.8 Hz, H-3), 4.32 (t, 1H,
J = 6.8 Hz, H-5), 4.15–4.08 (m, 3H, H-2, H-6a, H-6b),
2.20, 2.07, 2.00 (3s, 3H each, COCH3); 13C NMR
(100 MHz, CDCl3): d 170.8, 170.3, 170.1 (3 · COCH3),
3.9. p-Cresyl 3,4,6-tri-O-acetyl-a-D-galactopyranoside
(7b)
158.7 (JC4 ,F = 240.1 Hz, C-40), 152.3 (C-10), 118.4
0
[a]D +152.8 (c 1, CH2Cl2); 1H NMR (400 MHz, CDCl3):
d 7.13 (d, 2H, J = 8.4 Hz, H-20, H-60), 7.01 (d, 2H,
J = 8.4 Hz, H-30, H-50), 5.60 (d, 1H, J = 3.8 Hz, H-1),
5.49 (d, 1H, H-4), 5.37 (dd, 1H, J = 3.3, 10.4 Hz, H-
(JC ,F = 8.1 Hz, C-20, C-60), 116.1 (JC ,F = 23.1 Hz,
C30, C-50), 98.4 (C-1), 70.5, 68.1, 67.7, 67.2, 61.7 (C-6),
20.8, 20.6, 20.5 (3 · COCH3); ESI-MS: Calcd for
C18H21O9FNa ([M+Na]+): 423.1067, found: 423.1071.
0
0